本頁面由Tiger Fintech (Singapore) Pte. Ltd.提供服務

Aura Biosciences, Inc.

7.23
+0.17002.41%
盤後7.06-0.1700-2.35%19:09 EDT
成交量:12.22萬
成交額:87.56萬
市值:4.48億
市盈率:-3.80
高:7.25
開:7.11
低:7.00
收:7.06
資料載入中...
2022/05/12

季度報告

10-Q - Quarterly report [Sections 13 or 15(d)]
2022/03/23

員工持股計劃

S-8 - Securities to be offered to employees in employee benefit plans
2022/03/23

重要事件披露

8-K - Current report
2022/03/23

年度報告

10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2022/02/14

超過5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2022/02/14

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2022/02/10

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2022/01/26

超過5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2021/11/24

重要事件披露

8-K - Current report
2021/11/24

季度報告

10-Q - Quarterly report [Sections 13 or 15(d)]
2021/11/12

超過5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2021/11/12

超過5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2021/11/10

超過5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2021/11/10

超過5%披露

SC 13D - General statement of acquisition of beneficial ownership
2021/11/04

超過5%披露

SC 13D - General statement of acquisition of beneficial ownership
2021/11/02

重要事件披露

8-K - Current report
2021/10/29

員工持股計劃

S-8 - Securities to be offered to employees in employee benefit plans
2021/10/26

SEC問詢函

CORRESP [Cover] - Correspondence
2021/10/26

SEC問詢函

CORRESP [Cover] - Correspondence
2021/10/25

[修訂]招股説明書

S-1/A [Amend] - General form for registration of securities under the Securities Act of 1933